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Shigella is a highly adapted human pathogen, mainly found in the developing world
and causing a severe enteric syndrome. The highly sophisticated infectious strategy
of Shigella banks on the capacity to invade the intestinal epithelial barrier and cause
its inflammatory destruction. The cellular pathogenesis and clinical presentation of
shigellosis are the sum of the complex action of a large number of bacterial virulence
factors mainly located on a large virulence plasmid (pINV). The expression of pINV genes
is controlled by multiple environmental stimuli through a regulatory cascade involving
proteins and sRNAs encoded by both the pINV and the chromosome. The primary
regulator of the virulence phenotype is VirF, a DNA-binding protein belonging to the AraC
family of transcriptional regulators. The virF gene, located on the pINV, is expressed
only within the host, mainly in response to the temperature transition occurring when
the bacterium transits from the outer environment to the intestinal milieu. VirF then acts
as anti-H-NS protein and directly activates the icsA and virB genes, triggering the full
expression of the invasion program of Shigella. In this reviewwewill focus on the structure
of VirF, on its sophisticated regulation, and on its role as major player in the path leading
from the non-invasive to the invasive phenotype of Shigella. We will address also the
involvement of VirF in mechanisms aimed at withstanding adverse conditions inside the
host, indicating that this protein is emerging as a global regulator whose action is not
limited to virulence systems. Finally, we will discuss recent observations conferring VirF
the potential of a novel antibacterial target for shigellosis.
Keywords: VirF, Shigella, pathogenic E. coli, AraC proteins, transcriptional regulators, DNA binding proteins,
bacterial virulence, antivirulence therapy
INTRODUCTION
Bacterial pathogens must often survive within fundamentally diverse habitats. Dynamic adaptation
to the surroundings depends on the ability to sense environmental variations and to respond
in an appropriate manner. This involves drastic changes in the transcriptional program of the
cell. The capability to swiftly modulate gene expression requires investment by the bacterium in
numerous gene functions that not only allow adaptation to different milieus but also enable the
cell to co-ordinately rework its response to mutable conditions (Cases and de Lorenzo, 2005).
The complexity of gene expression in pathogenic bacteria can be viewed as an evolutionary
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response to the challenge of surviving in changing environments
(McAdams et al., 2004). Many pathogenic E. coli, including
Shigella, are able to live in complex environments and have
evolved intricate control systems. The expression of their
pathogenic phenotype is the result of a multifactorial process
which requires the synthesis of a large set of virulence
determinants that may not be simultaneously needed during all
stages of the infection process. These determinants are controlled
by global regulatory networks, integrating specific regulators with
conserved housekeeping processes.
Shigella is a facultative intracellular pathogen causing human
bacillary dysentery, also known as shigellosis, a highly infectious
disease widespread in developing countries. Although usually
self-limiting, shigellosis can be fatal, especially in children
(Anderson et al., 2016; Njamkepo et al., 2016; The et al.,
2016). The pathogenicity of Shigella relies on its capacity to
kill macrophages and invade colonic epithelial cells. Bacteria
multiply intracellularly and spread to adjacent cells, with
consequent cell death and inflammatory destruction of the
mucosa (Schroeder and Hilbi, 2008; Ashida et al., 2015). The
invasive process requires the coordinated expression of several
genes located on the chromosome as well as on a virulence
plasmid (pINV) (Sansonetti et al., 1982; Parsot, 2005). The
acquisition of the pINV, a large F-type plasmid, by horizontal
gene transfer (HTG) constitutes one of the most critical events
in the evolution of the pathogenic lifestyle of Shigella since it
encodes crucial elements of the molecular machinery required
for invasion and intracellular survival (Pupo et al., 2000; The
et al., 2016). pINV plasmids isolated from different Shigella spp.
share significant homology and carry about 100 genes and an
equivalent number of IS sequences (Buchrieser et al., 2000; Yang
et al., 2005). Most genes required for host cell invasion and
macrophage killing are contained in a conserved 31 kb region
which is arranged as a PAI-like structure (Maurelli et al., 1985;
Sasakawa et al., 1988). This so-called “entry region” consists
of 34 genes organized into two large, divergently transcribed
clusters. It contains the genes encoding the Ipa proteins, their
chaperons and a specific T3SS system (Parsot, 2005). Besides
these structural genes, the entry region hosts two regulatory
genes coding for VirB and MxiE, the transcriptional activators
required for the sequential expression of most pINV virulence
genes (Beloin et al., 2002; Mavris et al., 2002). Scattered along the
pINV, outside the entry region, are other genes encoding proteins
crucial for the invasive process: the IcsA protein, responsible
for the recruitment and polymerization of the host actin at one
pole of the bacterial cell (Bernardini et al., 1989); the PhoN2
protein, required for proper IcsA localization (Scribano et al.,
2014); the OspG protein, involved in the modulation of the host
innate immune response (Kim et al., 2005); the IpaH proteins,
Abbreviations: FIS, factor for inversion stimulation; HGT, horizontal gene
transfer; H-NS, heat stable nucleoid-structuring protein; HTH, helix-turn-
helix; IC50, half maximal inhibitory concentration; IHF, integration host
factor; Ipa, invasion plasmid antigen; IS, insertion sequence; MiaA, tRNA-
N6-isopentyladenosine synthetase; PAI, pathogenicity island; PCr, Congo red
phenotype; sRNA, small RNA; SAT, spermidine acetyl transferase; T3SS,
type III secretion system; TCS, two component system; TGT, tRNA-guanine
transglycosylase.
which interfere with the host ubiquitination-dependent protein
degradation (Ashida and Sasakawa, 2015); and the VirF protein,
the primary virulence regulator (Sakai et al., 1988; Prosseda et al.,
1998).
In this review we will focus on VirF summarizing its structure,
its sophisticated regulation, its role as major player in the
cascade of events leading to the activation of the virulence
program of Shigella, and its involvement in mechanisms aimed
at withstanding adverse conditions inside the host. We will also
address how these features confer VirF the potential of a novel
antibacterial target for shigellosis.
VirF, AN AraC-LIKE REGULATOR
VirF is a member of the AraC family of transcriptional regulators.
This large family contains more than 800 different proteins,
found mainly among gram negative bacteria and involved in the
regulation of carbon metabolism, stress response, and virulence
(Gallegos et al., 1997; Egan, 2002). The AraC proteins are
characterized by two structural domains: a conserved C-terminal
DNA binding domain and a more variable N-terminal signaling
domain. The two domains are connected by an unstructured
linker. DNA binding involves two helix-turn-helix (HTH) motifs
and has been studied by analyzing the structure of the MarA
(Rhee et al., 1998) and Rob (Kwon et al., 2000) proteins in
complex with their target DNA, leading to the proposal that two
different modes of DNA binding might exist involving either
one (Rob) or both (MarA) HTH motifs. The N-terminal region
is responsible for multimerization and/or binding of cofactors
(Egan, 2002). The AraC family has been traditionally divided
into three classes (Gallegos et al., 1997). The first one consists
of proteins which, like AraC, act as regulators in response to
a chemical signal (Schleif, 2010). Proteins involved in stress
response, such asMarA and Rob, constitute the second class. VirF
belongs to the third class, whose members control transcription
in response to a physical signal (like temperature) and mostly
serve as virulence gene regulators. While the proteins of the first
and third class act as homodimers, proteins of the second class
operate mainly as monomers. Members of the AraC family are
frequently insoluble proteins. Precise molecular characterization
of VirF and detailed information on its mechanism of action are
still scarce as purification of VirF has been obtained only in a
few cases (Porter et al., 2004; Tran et al., 2011). Most groups
(Tobe et al., 1993; Porter and Dorman, 2002; Koppolu et al.,
2013; Emanuele et al., 2014; Emanuele and Garcia, 2015) have
reported difficulties in isolating VirF in quantities suitable to
in vitro analysis and have therefore used a MalE—VirF fusion
protein which still retains VirF functionality despite the lack of
the first 10 N-terminal aminoacids ( Tobe et al., 1993; Koppolu
et al., 2013; Emanuele and Garcia, 2015).
VirF carries the two canonical AraC DNA-binding HTH
motifs within its C-terminus. To acquire structural and
functional information about the VirF protein, the entire virF
gene has been subjected to both, random and site-directed
mutagenesis and mutated proteins have been assayed for
their ability to activate the plasmid-encoded invasive genes by
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analyzing the expression of a mxiC-lacZ fusion (Porter and
Dorman, 2002). Mutating the key residues of the first HTHmotif,
in particular in the positioning helix (I180) or in the recognition
helix (K193), inactivates VirF. The second HTHmotif is essential
as well, since mutating the key residues (Y239 and I241), which
according to the MarA-DNA co-crystal (Rhee et al., 1998) form
specific contacts with DNA, leads again to VirF inactivation. The
functionality of VirF is hampered also by modifications in the
hydrophobic core of HTH2 or by deletion of the C-terminal
HTH2 region. This strongly suggests that VirF interacts with
its target sequences via both HTH motifs. Additional evidence
on the relevance of the two motifs to DNA binding stems from
studies on another AraC regulator, PerA, which shares significant
homology with VirF. This protein is required for the activation of
the bundle-forming pili in ETEC and is able to fully substitute
VirF in the activation of the Shigella virB promoter (Porter
et al., 2004). Mutations affecting the DNA-interacting nucleotides
from either of the two C-terminal HTH motifs of PerA have
been shown to inactivate the protein, indicating that also PerA
requires both HTH motifs to interact with its DNA targets
(Porter et al., 2004). However, while PerA and Rns, another
AraC-like regulator from ETEC (Porter et al., 1998), are able to
complement Shigella virF mutants, VirF is unable to restore the
expression of the PerA or Rns regulated genes, suggesting that
a particular DNA structure which forms only at Shigella VirF-
regulated promoters is required as signal for the activation of the
VirF protein (Porter and Dorman, 2002; Porter et al., 2004).
AraC and several members of the AraC family are known
to form homodimers (Gallegos et al., 1997; Egan, 2002; Schleif,
2010) and the residues required for self-association are contained
in the N-terminal domain. As yet the only evidence suggesting
that VirF may act as dimer/oligomer stems from the observation
that two mutants unable to bind DNA are dominant negative
when co-expressed with the wild type VirF. However, the fact that
other HTH1 or HTH2 mutations have no trans-dominant effect
rises the possibility (Porter and Dorman, 2002) that VirF binds
first as monomer and then, following DNA bending and DNA-
DNA interactions, forms a multisubunit nucleoprotein complex,
as previously observed in the case of the melibiose-dependent
activator MelR (Bourgerie et al., 1997). This is consistent with
the observation that a MalE—VirF fusion protein recognizes a
single, large (about 100 bp) region on the virB promoter (Tobe
et al., 1993). However, recent footprinting analyses using purified
VirF and revealing the presence of four distinct VirF binding
sites (each spanning 40–60 bp) within the icsA-RnaG regulatory
region (Tran et al., 2011) indicate that, rather than interacting at
a single large spot, VirF recognizes its target sites with different
affinities and may give rise to a large nucleoprotein complex only
at higher protein concentration.
VirF IS AT THE TOP OF THE VIRULENCE
REGULATORY CASCADE
The transcriptional activation of the invasive operons relies on
the response to environmental stimuli like temperature, pH,
and osmolarity, commonly encountered in the human intestine
(Schroeder and Hilbi, 2008). This process requires the VirF
protein (Sakai et al., 1988; Adler et al., 1989; Falconi et al., 1998;
Durand et al., 2000) which, through a sophisticated regulatory
cascade (Dorman and Porter, 1998; Prosseda et al., 2002; Parsot,
2005), leads to the full expression of the virulence phenotype
(Figure 1). Temperature is a crucial factor since transcription of
the pINV invasion genes is strongly repressed at 30◦C by the
chromosome-encoded protein H-NS (Maurelli and Sansonetti,
1988; Falconi et al., 1998). The primary event following the
upshift of Shigella to the host temperature (37◦C) is the synthesis
of VirF which acts as an antisilencer, relieving H-NS mediated
repression at the virB (Tobe et al., 1993) and icsA (Tran et al.,
2011) loci. This is not uncommon: in many bacterial pathogens
H-NS, one of the major components of the bacterial nucleoid,
acts as transcriptional silencer of virulence genes located on
mobile genetic elements (Dorman, 2004, 2007). As for the icsA
gene, it encodes an outer membrane protein which promotes the
intra- and intercellular spreading of Shigella among the epithelial
cells of the colon (Bernardini et al., 1989; Lett et al., 1989). The
other VirF-activated gene encodes a secondary transcriptional
FIGURE 1 | Centrality of VirF in the pINV regulatory cascade of
Shigella. The control of VirF occurs at transcriptional and translation levels.
The major proteins involved in the regulation of VirF in response to
environmental stimuli and nutrient conditions are indicated. Once synthesized,
VirF activates the icsA and virB genes and represses the synthesis of the
sRNA RnaG. VirB, the second regulator, then activates several operons,
including those for a T3SS system and for the early effectors. VirB activates
also the last regulator, MxiE, which in association with IpgC activates the late
effectors. TCS, two component system.
Frontiers in Molecular Biosciences | www.frontiersin.org 3 September 2016 | Volume 3 | Article 61
Di Martino et al. The Shigella VirF Regulator
activator, VirB, which antagonizes the repressive activity of H-NS
at the promoters of several pINV virulence genes by remodeling
the DNA within H-NS-DNA nucleoprotein complexes (Beloin
et al., 2002; McKenna et al., 2003). In particular, VirB activates,
among others, the genes coding for the Shigella T3SS (Mxi
and Spa proteins), for its early effectors and their chaperones
(Ipa and Ipg proteins), and for MxiE, the last regulator in
the cascade (Parsot, 2005; Schroeder and Hilbi, 2008). MxiE
is another AraC-like protein (Kane et al., 2002; Mavris et al.,
2002) which positively controls the expression of the late effectors
but it becomes available as activator only when the IpgC
chaperone facilitates its release from an anti-activator complex
(OspD/Spa15).
The role of VirF as positive activator was first evidenced by
observing that in S. flexneri (Sakai et al., 1988) and in S. sonnei
(Kato et al., 1989) the expression of the four Ipa antigen proteins
and of IcsA (known also as VirG) is silenced in the absence of
VirF and increased when VirF is over expressed. It was then
demonstrated (Adler et al., 1989; Tobe et al., 1991) that the
regulatory activity of VirF is exerted directly when it interacts
with the icsA gene, while it occurs indirectly, i.e., through the
mediation of VirB, on the ipa operons. This gave the first basis
for the classic cascade model. Originally, the regulatory role of
VirF remained unclear and the protein was simply regarded
as the element responsible for the capacity of Shigella to bind
Congo red, a phenotype (Pcr+) associated with the expression
of virulence (Sakai et al., 1986a). Initial molecular analyses of
the pINV had led to the identification of an about 1 kb region
responsible for the Pcr+ phenotype in E. coli. This region turned
out to be located within the F fragment of a SalI pINV restriction
digests and contained a gene, hence named virF, which was
shown to be essential but not sufficient for the full expression of
virulence in S. flexneri (Sakai et al., 1986a,b). Additional support
to the active role played by VirF as regulator banks on the
observations that its intracellular concentration is strictly related
to the expression of virulence genes, that a VirF threshold level is
required for the activation of the second regulator, virB, and that
overexpression of virF fully restores the invasive phenotype at
non-permissive temperature or in pINV-integrated strains (Adler
et al., 1989; Dagberg and Uhlin, 1992; Colonna et al., 1995;
Prosseda et al., 1998; Durand et al., 2000).
Cloning and sequencing analyses of the pINV plasmid have
revealed that, in contrast to virB which is localized within the 31
kb PAI, the virF gene constitutes a “desert island” located 60 kb
outside the PAI and surrounded by a mosaic of IS sequences
(Buchrieser et al., 2000; Venkatesan et al., 2001; Prosseda et al.,
2006), suggesting that it might have been acquired by the plasmid
genome independently from the “entry region” (Prosseda et al.,
2002). Besides its position, one of the striking features of the
virF sequence is its low GC content—about 30%; interestingly
this is true also for other virulence-related genes in the 31 kb
PAI—as compared to that of the whole pINV plasmid and of the
Shigella chromosome, which are about 48 and 50%, respectively
(Buchrieser et al., 2000; Venkatesan et al., 2001; Yang et al.,
2005). The virF gene exhibits canonical −35 and −10 regulatory
boxes, however no clear ribosome binding site is found. While
attempting to purify the protein it has been observed that VirF
exists in three different forms: 30, 27, and 21 kDa (Sakai et al.,
1986b; Kato et al., 1989). The larger form has been considered the
active one while as yet no functional activity has been attributed
to the two minor forms.
Strong evidence that VirF acts as a DNA binding protein
capable to activate virB transcription by interacting with the
upstream region of the virB promoter comes from the studies of
Tobe et al. (1993). By deletion analysis of the virB promoter the
authors have shown that the activation of virB requires a region
of 110 bp upstream the transcription start site. The relevance of
this region has been confirmed in the same study by footprinting
with a MalE—VirF fusion protein. This allowed to identify a
VirF binding site spanning from −117 to −17 which, by in vitro
transcription, proved to be essential for the activation of virB.
Considering the position of the VirF binding site and its role
as activator, it has been proposed that VirF could act either by
recruiting RNA polymerase at the virB promoter or by improving
the ability of RNA polymerase to form an open complex (Tobe
et al., 1993). The positive effect of VirF on virB transcription is
counteracted by H-NS which has been shown to occupy a virB
promoter region (spanning from−20 to+20) encompassing the
RNA polymerase binding site (Tobe et al., 1993). Since the H-NS
and VirF binding sites at the virB promoter are contiguous, it has
been speculated that the binding of VirF may disrupt the H-NS-
DNA repression complex, possibly being favored by thermally-
induced changes in local supercoiling (Tobe et al., 1993). The
relevance of superhelicity per se is supported by the finding
that virB activation by VirF occurs much more efficiently on
supercoiled templates than on relaxed ones (Tobe et al., 1993).
As mentioned before, also the icsA gene is controlled by VirF
(Sakai et al., 1988). This gene encodes a protein responsible
for the motility of Shigella and is located on the pINV plasmid
outside the “entry region” (Bernardini et al., 1989; Lett et al.,
1989). In contrast to all other structural genes involved in the
invasive process, icsA does not require VirB (Figure 1). As is
the case of virB, also icsA is repressed by the binding of H-NS
to its regulatory region (Prosseda et al., 1998). This occurs
at three sites (H-NS I, H-NS II, and H-NS III) and severely
reduces icsA transcription at 30◦C (Tran et al., 2011). Recent
evidence shows that the regulation of icsA also depends on
RnaG, a small antisense RNA transcribed on the complementary
strand of icsA (Giangrossi et al., 2010). RnaG downregulates
icsA transcription by means of two independent mechanisms,
transcriptional interference, and transcriptional attenuation. In
the first case the expression of RnaG decreases the activity of
the icsA promoter. In the second case RnaG causes a premature
termination of the icsA transcript (Giangrossi et al., 2010).
Experiments performed with purified VirF indicate that this
protein is able to directly stimulate the expression of icsA and
that it binds to four 40–60 bp sites, two of which overlap the
icsA and RnaG promoters (Tran et al., 2011). This region hosts
H-NS sites I and II. The relative position of binding sites for
H-NS and VirF provides a physical basis for a possible functional
competition between the two proteins. By monitoring the icsA
promoter activity in the presence of both H-NS and VirF it
has been shown that VirF is able to significantly counteract the
H-NS-dependent inhibition at the icsA promoter, thus acting as
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an anti-H-NS protein. VirF expression increases rapidly when
temperature is raised above 32◦C (Falconi et al., 1998; Prosseda
et al., 1998; Durand et al., 2000; Figure 2). It is possible to
speculate that at the host temperature (37◦C) the increased
amount of VirF may facilitate the interaction with its sites and
consequently disrupt the H-NS-DNA complexes by forming
a putative H-NS-icsA-VirF intermediate able to promote the
switch from a repressed to an active state (Tran et al., 2011).
Besides inducing icsA activation, VirF is also able to repress
the expression of RnaG (Figure 1) by binding to a specific
site overlapping the RnaG promoter. Thus, VirF promotes icsA
expression in two ways: by acting on icsA both directly and
indirectly, i.e., via repression of RnaG transcription (Tran et al.,
2011). Altogether the experimental evidence existing on the role
of VirF as major regulator in the cascade of events regulating the
virulence of Shigella highlights the antagonism between H-NS
and AraC proteins, suggesting that this may be a common
evolutionary strategy that pathogens adopt to control virulence
genes (Egan, 2002; Dorman, 2004).
THE REGULATION OF THE virF GENE
The switch from the non-invasive to the invasive phenotype
in Shigella is an elaborate process and the complexity of the
regulatory mechanisms the virF gene undergoes is therefore
not surprising. The expression of virF is affected by different
environmental signals that act through highly diversified
mechanisms. Nucleoid-associated proteins are known for their
contribution to the transcriptional control of several genes
including virulence genes (Rimsky and Travers, 2011). This is
well exemplified in the case of virF (Prosseda et al., 2002) where
H-NS (Falconi et al., 1998), FIS (Falconi et al., 2001), and IHF
(Porter and Dorman, 1997b) are deeply involved as regulative
elements.
The first studies aimed at understanding the temperature-
regulated expression of the invasion phenotype of Shigella
demonstrate that H-NS, originally designated virR (Maurelli and
Sansonetti, 1988; Hromockyj et al., 1992), is responsible for
silencing invasive genes at 30◦C. Indeed, hns-defective mutants
were shown to express the virulence determinants also at
non-permissive temperature. Successive reports have revealed
that the thermo-dependent expression of virF is lost in a Shigella
hns-defective background, providing clear evidence that H-NS
is able to affect the regulation of the virF gene (Dagberg and
Uhlin, 1992; Colonna et al., 1995) and that this capacity is based
on the ability of H-NS to bind the virF promoter with strong
specificity (Prosseda et al., 1998). A detailed analysis (Falconi
et al., 1998) of how H-NS interacts with the virF gene indicates
that, both in vivo and in vitro, this protein is able to recognize
and repress virF only below a critical temperature (32◦C). This
temperature-dependence relies on the interaction of H-NS with
two binding sites within the virF promoter, spaced by a DNA
linker region. The accessibility of the target DNA to H-NS varies
significantly with temperature and H-NS is able to recognize
its binding boxes only at lower temperature: with increasing
temperature H-NS binding decreases, and at a temperature
higher than 30◦C the virF promoter becomes insensitive to
H-NS repression. The position of the two H-NS binding sites
on the virF promoter has been investigated in detail (Falconi
et al., 1998). They have been mapped through in vivo and in
vitro footprinting experiments and are localized around positions
FIGURE 2 | Temperature-dependent regulation of the promoter of the virF gene. The virF promoter contains two H-NS (indicated in green) and four FIS
(indicated in orange) binding sites (Falconi et al., 1998, 2001). The arrow on the top of the figure indicates the transition from the outer environment (colder) to the
intestinal host milieu (warmer). Left panel: At lower temperature a compact structure exists where H-NS represses virF by interacting with H-NS binding sites I and II
which are separated by a DNA region whose sequence-mediated curvature is favored by the lower temperature. Middle panel: The intrinsic bend located between the
two H-NS binding sites melts abruptly around 32◦C and the bending center slides downstream unmasking a binding site for FIS. Right panel: By increasing the
temperature the DNA bend relaxes further, H-NS interactions to binding sites I and II weaken and FIS gains easier access to its binding boxes, thus counteracting
H-NS repression. Altogether these events lead to the formation of an active transcription complex.
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−250 (binding site II) and−1 (binding site I) with respect to the
virF transcription start site. Site I overlaps the canonical−35 and
−10 regulatory elements, suggesting that this region is involved
in the transcriptional repression of the virF gene by H-NS: the
interaction of H-NS with DNA may prevent the −35 and −10
boxes to be accessed by RNA polymerase (Figure 2). Binding site
II maps far upstream the−35 and−10 sequences. In the absence
of this site, H-NS forms a very unstable nucleoprotein complex,
which cannot compete with RNA polymerase effectively. The
DNA linker region separating the two H-NS binding sites is
endowed with sequence-mediated curvature, a feature whose
amplitude is inversely dependent on temperature (Prosseda
et al., 2004, 2010). This DNA bend progressively relaxes with
increasing temperature and is rapidly abolished above 32◦C
(Figure 2).
The fact that H-NS binding to the virF promoter, bending
of the promoter region and repression of virF transcription
are all sharply decreased by raising the temperature above
a critical threshold suggests that the physical basis for the
thermoregulated expression of virF resides in a temperature-
dependent structural transition of the virF promoter, with the
curved DNA tract within the promoter operating essentially as
a thermosensor (Falconi et al., 1998). According to this model,
with increasing temperature the transcriptionally inactive DNA
architecture prevailing at low temperature would be replaced by
a more relaxed geometry which no longer hinders the formation
of a functional transcription complex (Falconi et al., 1998). This
view has received further support by successive experiments
(Prosseda et al., 2004) where the decreased DNA curvature
of the virF promoter induced by raising the temperature is
mimicked, at constant temperature, by templates (obtained
by a targeted in vitro mutagenesis procedure) endowed with
decreasing intrinsic DNA curvature. The results of footprinting
and in vivo transcription assays using these templates highlight
a strict correlation between intrinsic DNA curvature and the
capability of H-NS to bind to its target sites and repress virF
transcription. Moreover, the reciprocal rotational position of
the two H-NS sites appears crucial for the thermoregulation
of virF: moving the sites by about a half helix turn further
apart produces templates which, despite a comparable overall
bending level, are almost insensitive to H-NS repression, likely
because the protein can no longer form a tight, transcription-
blocking nucleoprotein complex. Temperature does not only
affect the amplitude of the DNA bend within the virF promoter
but also the position of the bending center, identified by
means of circular permutation assays (Prosseda et al., 2004):
at 4◦C this spot maps at position −137 but with increasing
temperature it slides downstream (up to position −55 at
60◦C) within the region bounded by the two H-NS sites
(Figure 2).
The complexity of the interaction between H-NS and bent
DNA is increased further by the participation of FIS (Falconi
et al., 2001). In agreement with the well-known growth phase
dependent expression of FIS (Rimsky and Travers, 2011), the
effect of this protein is higher in early exponential phase (Falconi
et al., 2001), suggesting that it contributes to rapidly increase virF
expression once bacteria have entered the host environment. FIS
exerts, both in vivo and in vitro, a direct positive control on the
transcription of virF and is able to bind to the virF promoter.
Four FIS binding sites (I to IV), centered around positions +55
(site I), −1 (site II), −130 (site III, almost coinciding with the
−137 position of the DNA bending center), and −200 (site IV),
have been identified in the virF promoter region (Falconi et al.,
2001). The interaction of FIS with site II likely hampers H-NS
binding to its boxes. The downstream sliding of theDNAbending
center and the concomitant curvature decrease occurring with
increasing temperature favor the binding of FIS to the other
sites inducing an adjustment to the geometry of the DNA that
hinders long range H-NS/H-NS interaction, thus promoting
the transcription of virF. Several reports have stressed the
validity of this model—envisaging an environmentally induced
structural collapse of a promoter’s intrinsic bend as a regulative
key—also among other pathogenic bacteria, like Y. enterocolitica
virF (Rohde et al., 1999), and E. coli hly (Madrid et al.,
2002).
Besides FIS also IHF is involved in the positive control of
the pINV regulon by stimulating the transcription of the virF
and virB genes (Porter and Dorman, 1997b). IHF is composed
by two subunits encoded by the ihfA and ihfB genes (Rimsky
and Travers, 2011). IHF binds to the virF, virB, and icsA
promoters. In the case of virF it recognizes a 127 bp fragment
spanning from the promoter-proximal sequence to the start
of the ORF, with a putative binding site located between +45
and +57. In ihfA-defective strains entering stationary phase the
expression of the Ipa proteins and of the T3SS components
is decreased as a consequence of the reduced level of VirF
and VirB (Porter and Dorman, 1997b). This growth-phase-
dependent effect is consistent with the increased level of IHF
during late growth phases (Rimsky and Travers, 2011). However,
the observation that in a ihfA mutant virulence gene expression
is reduced only two- to three-fold suggests that IHF, rather
than constituting an absolute requirement, plays a modulatory
role.
The expression of the Shigella invasive genes is repressed
at low pH and low osmolarity (Porter and Dorman, 1997a).
Also in these cases regulation occurs mainly at the level of
virF expression. While it has been demonstrated that H-NS
is involved, at least in part, in the repression of virF under
low osmotic conditions (Mitobe et al., 2009), the pH-dependent
regulation of virF requires the two component regulatory system
CpxA/CpxR (Nakayama and Watanabe, 1995, 1998; Figure 1).
The Cpx system responds to a broad range of stimuli including,
besides pH, also salt, metals, lipids, and misfolded proteins that
cause perturbations in the bacterial envelope (Raivio, 2014).
In particular, it has been shown that the response regulator
CpxR binds directly to a fragment containing the upstream
promoter region of virF between positions −103 and −37.
Phosphorylation of CpxR enhances its binding capacity and
directly activates the transcription of virF (Nakayama and
Watanabe, 1998). Due to the relevance of the CpxA/CpxR system
in response to several stimuli connected to envelope stress,
the integration of virF within the CpxR-controlled network
represents a further regulatory layer acting on the fine control
of VirF.
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Besides being subject to a complex transcriptional control
the virF gene is also regulated at the translational level.
It has been shown that post-transcriptional modifications
of tRNA affect the translation of VirF (Figure 1). The full
expression of S. flexneri virulence genes depends on the presence
of two modified tRNA nucleosides (queuosine, at position
34, and 2-methylthio-N6-isopentenyladenosine, adjacent to 3′-
end of the anticodon). The synthesis of these nucleosides
depends on the products of the tgt (encoding TGT, the
tRNA-guanine transglycosylase) and miaA (coding for MiaA,
a tRNA-N6-isopentyladenosine synthetase) genes, respectively.
The intracellular concentration of VirF decreases in tgt mutants
and in miaA mutants, inducing a low virulence phenotype
and an avirulent phenotype, respectively (Durand et al., 1994,
1997). Overall, tRNA modifications are required for VirF to
reach the threshold level necessary to activate the virulence
cascade (Durand et al., 2000). Besides being involved in tRNA
modification TGT also recognizes (Hurt et al., 2007) the virF
mRNA in vitro and this recognition results in a site-specific
modification at position 421 responsible for the change from
guanine to adenine in the mRNA. As yet the physiological
significance of this modification is unclear. A contribution of
tRNA modification enzymes in virulence has been reported also
in other systems: the GidA and MnmE enzymes, which act
together as a complex, are both required for the expression of
the full virulence phenotype in Salmonella enterica, Aeromonas
hydrophila, and in the plant pathogen Pseudomonas syringae
(Shippy and Fadle, 2014). Morevoer, the GidA/MnmE complex
has been shown to be relevant for the stress response in
Salmonella and MiaA is essential in E. coli for growth at higher
temperature (Tsui et al., 1996).
Finally, a connection between bacterial metabolism and
virulence gene expression has been found in S. flexneri, observing
that the addition of ornithine to minimal medium reduces virF
expression while the addition of putrescine, lysine and few other
aminated metabolites counteract this inhibition (Durand and
Björk, 2003, 2009). Moreover, it has been observed that proteins
involved in the glycolytic pathway, most notably the carbon
regulator CsrA, are required for the full expression of the Shigella
virulence phenotype: indeed, the inactivation of csrA causes a
significant reduction of virF and virB expression (Gore and
Payne, 2010). As yet the molecular mechanism adopted by CsrA
to control these genes is unknown.
VirF AS GLOBAL REGULATOR
The evolution of bacterial pathogens from harmless ancestors
mainly depends on the acquisition of virulence gene clusters
on plasmids, phages, and pathogenicity islands by HGT.
This process is complemented by the progressive adaptation
to a specific niche determined by so-called pathoadaptive
events such as mutations, rearrangements or deletions of
genes unnecessary, or even deleterious, for optimal fitness
to the new environment (Ochman and Moran, 2001). These
events usually involve the concomitant acquisition or loss of
regulatory factors which modify the transcriptional profile of
the host to a significant extent. The evolution of Shigella
from E. coli is a most studied exemplification of these events
(Prosseda et al., 2012).
Global transcriptional analyses of E. coli cells expressing or
lacking the virF gene have contributed to understand to what
extent the arrival of VirF by the acquisition of the pINV plasmid
in Shigella has altered the transcriptional program of the ancestor.
These studies have revealed that the activity of VirF is not
restricted to the regulation of plasmid-encoded virulence genes
as icsA and virB but extends also to chromosomally-located genes
(Barbagallo et al., 2011). Genes activated by VirF can be grouped
into two categories: those which are functional both in Shigella
and E. coli, and those that have been inactivated in Shigella.
Among the more VirF-sensitive genes of the first group there
are those encoding the heat shock proteins IbpA, GroESL, HtpG,
DnaK, and Lon. Given the protective role exerted by these stress
proteins, it can be hypothesized that the functional significance
of VirF resides in activating genes which contribute to better
withstand adverse conditions inside the host.
The existence of VirF-regulated genes silent in Shigella (i.e.,
the second group) suggests that some of themmay encode factors
perturbing the invasive process which likely have been silenced
during evolution in order to optimize bacterial fitness within
the host. Most of these genes encode yet unknown products.
In this respect the speG gene, encoding the enzyme spermidine
acetyl transferase (SAT), is an exception. In E. coli, SAT prevents
the accumulation of spermidine (and the consequent toxic
effects) by catalyzing the conversion of this polyamine into its
physiologically inert form, acetylspermidine (Barbagallo et al.,
2011). The speG gene belongs to the ynfB-speG operon (no
function is as yet known for the ynfB product), whose induction
by VirF has been observed only at 37◦C (Barbagallo et al., 2011)
in agreement with the thermodependency of virF expression
(Falconi et al., 1998). The loss of speG constitutes a pathoadaptive
mutation (Prosseda et al., 2012; Campilongo et al., 2014) since
spermidine accumulation induced by the lack of SpeG activity
increases Shigella survival inside macrophages and its resistance
to oxidative stress conditions (Barbagallo et al., 2011). These data
have led to hypothesize that, during the evolutionary transition
from E. coli to Shigella, the acquisition of virF on the pINV
plasmid might have caused an increased expression of speG, thus
lowering the intracellular spermidine content (Di Martino et al.,
2013). Evidence supporting this view stems from the observation
that in Shigella speG expression is decreased in a VirF-defective
background and that restoration of speG expression lowers the
bacterial fitness within macrophages (Barbagallo et al., 2011).
Recently VirF has been shown to be involved in the regulation
of mdtJI, another operon related to polyamine function in
bacteria. In E. coli the mdtJI operon, which encodes an eﬄux
pump belonging to the small multidrug resistance family of
transporters, is almost silent because of a strong repression by
H-NS (Leuzzi et al., 2015). Despite the high homology between
Shigella and E. coli, in Shigella the mdtJI pump is expressed
because the H-NS repressive effect is counteracted by VirF
and favored by high levels of spermidine (Leuzzi et al., 2015).
Intracellular spermidine does not affect the synthesis of VirF
(Leuzzi et al., 2015) and the molecular mechanism by which
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this polyamine contributes towards the activation of mdtJI is
still unclear. Genetic studies on the expression of mdtJI in
Shigella indicate the presence of a VirF binding site around
the promoter consensus boxes which partially overlaps an H-NS
site, supporting the occurrence of a competition between the
two proteins (Leuzzi et al., 2015), in close analogy with the
observations on the virB and icsA promoters (Tobe et al., 1993;
Tran et al., 2011). In Shigella MdtJI promotes the secretion of
putrescine, the precursor of spermidine, and it has been proposed
that VirF- and spermidine-mediated activation of the mdtJI
operon represents a safety mechanism allowing spermidine to
accumulate within the bacterial cell to a level optimally suited for
survival within infectedmacrophages and, at the same time, avoid
toxic side effects on bacterial viability due to spermidine excess
(Leuzzi et al., 2015). Altogether, the observations on the ability
of Shigella to activate chromosomal genes evidence the extent to
which the acquisition of a new regulator by HGT represents a
crucial event for reshaping the transcriptional profile of the core
genome, facilitating bacterial adaptation to specific niches within
infected hosts.
VirF AS NOVEL TARGET FOR
ANTI-VIRULENCE THERAPIES
Each year Shigella is responsible for 125 million cases of
illness, mainly in low income countries (The et al., 2016).
Despite the enormous clinical relevance of these infections
and the emergence of multiresistance strains, no vaccine has
been as yet released for public use (Anderson et al., 2016).
Several recent studies have focused on the development of
novel treatment strategies targeting virulence instead of bacterial
viability, since this is regarded as a highly effective approach
to combat bacterial infections while minimizing the emergence
of antibiotic resistances (Rasko and Sperandio, 2010). The
expression of virulence factors is not required for cell viability
and therefore bacterial pathogens should be subject to less
selective pressure to develop resistance to inhibitors of virulence
determinants. AraC proteins are considered very interesting
candidate targets in anti-virulence strategies due to their critical
role in controlling virulence in pathogenic bacteria (Rasko and
Sperandio, 2010). Specific inhibitors can affect AraC-mediated
processes at different stages, such as self-association, DNA
binding, and recruitment of RNA polymerase.
As for shigellosis it is therefore not surprising that VirF
has been considered a very good antivirulence target, since its
silencing prevents host cell invasion and intercellular spreading
without affecting bacterial viability (Sakai et al., 1988; Falconi
et al., 1998). So far, two approaches have been adopted to
identify potential VirF inhibitors: a high-throughput screening
for small molecules and a targeted search among already
characterized AraC inhibitors. In the first case (Hurt et al.,
2010), the expression of virB in response to VirF has been
analyzed using a pINV-cured S. flexneri strain harboring a
recombinant plasmid containing the virF gene and a virB-lacZ
fusion. The screening, performed initially on 42,000 compounds
from several small-molecule libraries and then extended to an
additional set of 100,000 compounds, has led to the identification
of about 600 molecules meeting the selection criteria for VirF
inhibition (Hurt et al., 2010; Emanuele et al., 2014). After
selecting for candidates with favorable medicinal chemistry,
low toxicity and a dose-dependent activity, five compounds
able to inhibit VirF-driven transcriptional activation with very
low IC50 values were considered for further studies. These
compounds were characterized by the presence of aromatic
or heterocyclic rings that could interact with DNA or with
aromatic acids that typically associate with DNA (Hurt et al.,
2010; Emanuele et al., 2014). In vivo assays on cell cultures
have shown that only one polycyclic compound, named
19615 (methyl-[2-(2-phenyl-4a,9b-dihydro-benzo[4,5]furo[3,2-
d]pyrimidin-4-γ1oxy9-ethyl]-amine), was able to severely affect
intercellular spreading and induce a significant inhibition of
cell invasion (Emanuele and Garcia, 2015). In particular this
molecule has been demonstrated to be able to directly interact
with a MalE—VirF fusion protein and inhibit its binding to
the virB promoter. Further studies to structurally optimize the
selected compound are required to fully clarify its effectiveness in
an antivirulence therapy.
The second approach (Koppolu et al., 2013) adopted so
far to identify possible VirF inhibitors has been centered
on a small molecule, SE-1, a quinoline derivative [1-butyl-4-
nitromethyl1-3-(quinolin-γl)-4Hquinoline] previously identified
as an inhibitor of two AraC activators, RhaS, and RhaR
(Skredenske et al., 2013). Since SE-1 interacts with the conserved
DNA-binding domains of the AraC proteins (Skredenske et al.,
2013), it has been considered able to potentially inhibit also other
AraC activators. This turned out to be true: the data revealed
that SE-1 induced a significant reduction in the expression of
all VirF-controlled genes, consequently inhibiting the invasion
of epithelial cells. SE-1 binds directly to a MalE—VirF fusion
protein, a feature likely responsible for inhibiting VirF to interact
with DNA and activate transcription. On account that SE-1 does
not affect the growth of Shigella and does not have detectable
toxicity in human cell cultures, it has been considered as another
good candidate as novel antibacterial agent.
CONCLUSIONS AND PERSPECTIVES
Altogether the available data stress how Shigella, in its long
route to becoming a successful pathogen, has evolved an
elaborate regulatory system to ensure the coordinated activation
of virulence determinants or prevent their wasteful expression,
depending on environmental signals. The complexity of the
circuitry regulating virulence in Shigella highlights the relevance
of the firing of a major regulator, the virF gene, to the successful
development of the invasive program. Through studies analyzing
the interplay, either synergistic or antagonistic, among nucleoid-
associated proteins, sRNA, global, and specific regulators, and
intrinsic features of the DNA, the complex nature of the
regulation of VirF and of the genes under its control is emerging
with intriguing detail. However, while the master regulator has
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been identified almost three decades ago, several open questions
still exist, such as the capacity of VirF to form dimers or more
complex aggregates and the molecular mechanisms underlying
its DNA binding specificity and its interactions with RNA
polymerase. Understanding how the gene regulatory circuitry has
evolved in bacterial pathogens represents a challenge. From the
evolutionary standpoint this relates to the need to understand
how genes acquired by HGT have integrated into existing
regulatory networks and how newly acquired regulators have
shaped the genome of the new bacterial host. In the long run
a better understanding of the structure of the VirF protein can
be expected to positively impact on the development of new
therapeutic approaches based on the use of specific inhibitory
compounds.
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